Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
308,713,740
-
Total 13F shares
-
305,055,395
-
Share change
-
-2,191,723
-
Total reported value
-
$2,873,666,151
-
Put/Call ratio
-
110%
-
Price per share
-
$9.42
-
Number of holders
-
285
-
Value change
-
-$29,117,094
-
Number of buys
-
131
-
Number of sells
-
143
Institutional Holders of AMICUS THERAPEUTICS, INC. - Common Stock (FOLD) as of Q4 2024
As of 31 Dec 2024,
AMICUS THERAPEUTICS, INC. - Common Stock (FOLD) was held by
285 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
305,055,395 shares.
The largest 10 holders included
VANGUARD GROUP INC, WELLINGTON MANAGEMENT GROUP LLP, BlackRock, Inc., PERCEPTIVE ADVISORS LLC, Avoro Capital Advisors LLC, WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC, STATE STREET CORP, CITADEL ADVISORS LLC, Palo Alto Investors LP, and JPMORGAN CHASE & CO.
This page lists
287
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.